@inbook {7577,
	title = {Waldenstr{\"o}m{\textquoteright}s macroglobulinemia},
	booktitle = {Neoplastic Diseases of the Blood},
	year = {2013},
	note = {Export Date: 21 February 2017},
	month = {2013},
	pages = {681 - 699},
	abstract = {Waldenstr{\"o}m{\textquoteright}s macroglobulinemia is a neoplastic disorder of the B lymphocytes that is characterized by the infiltration of the bone marrow by a lymphoplasmatic clone that produces a monoclonal immunoglobulin which is always of the IgM type. WM is named after Jan Waldenstr{\"o}m, a Swedish physician who first described two patients who presented with oronasal bleeding, lymphadenopathy, anemia and thrombocytopenia, elevated erythrocyte sedimentation rate, high serum viscosity, normal bone radiographs, and bone marrow showing predominantly lymphoid cells. At that time electrophoresis of the serum proteins was not available; however, he attributed the hyperviscosity to an abnormal high-molecular-weight serum protein, which subsequently was shown to be a monoclonal immunoglobulin of the M class (IgM). Indeed, these two first patients presented with several of the most common features of WM, as have been subsequently described. {\textcopyright} 2013 Springer Science+Business Media New York. All rights reserved.},
	keywords = {monoclonal gammopathy of undetermined significance, Monoclonal gammopathy of undetermined significance diagnosis, Monoclonal gammopathy of undetermined significance management, Waldenstr{\"o}m{\textquoteright}s macroglobulinemia diagnosis, Waldenstr{\"o}m{\textquoteright}s macroglobulinemia treatment, Wladenstom{\textquoteright}s macroglobulinemia differential diagnosis, Wladenstrom{\textquoteright}s macroglobulinemia epidemiology},
	url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-84929554315\&doi=10.1007\%2f978-1-4614-3764-2_35\&partnerID=40\&md5=d4b13c5ae8870699542af2f86c4ff7cd},
	author = {Kastritis, E. and Dimopoulos, M.A.}
}
